Biofrontera Inc.
BFRI
$1.54
-$0.02-1.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 88.66% | -13.06% | 504.01% | -17.29% | -1,971.60% |
| Total Depreciation and Amortization | -11.71% | -14.61% | -0.45% | -33.65% | -28.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 178.72% | 392.80% | -1,656.00% | -33.93% | 102.76% |
| Change in Net Operating Assets | -185.75% | 3,593.20% | -7,005.56% | -37.82% | 460.23% |
| Cash from Operations | 45.55% | 98.30% | -133.63% | -216.47% | 35.49% |
| Capital Expenditure | 100.00% | -66.67% | 200.00% | -- | -102.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -66.67% | 300,200.00% | -- | 50.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -41.98% | 100.00% | 60.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.40% | 98.18% | -1.88% | -153.78% | 870.46% |